ACTRN12605000770662
Completed
Phase 2
A pilot study to explore the tolerability and efficacy of bortezomib as part of induction and post-transplant therapy in multiple myeloma
Clinical Haematology & Bone Marrow Transplant Unit, Royal Adelaide Hospital0 sites60 target enrollmentNovember 30, 2005
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Clinical Haematology & Bone Marrow Transplant Unit, Royal Adelaide Hospital
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Previously untreated, advanced multiple myeloma, planned for autologous PBSCT, absence of significant co\-morbidity.
Exclusion Criteria
- •No exclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A pilot study to assess the tolerability and the effectiveness of combination treatment of olanzapine and escitalpram for bipolar depression in Japamajor depressive episode of bipolar disorderJPRN-UMIN000014204Department of Psychiatry, Hokkaido University Hospital60
Active, not recruiting
Not Applicable
Study to compare two gels that are used to treat acne vulgaris. It will be compared the tolerability and effectivity following application of two combination topical acne products clindamycin 1% and 0.025% tretinoin gel (Acnatac® Gel), adapalen 0,1% and benzoyl peroxide 2,5% gel (Epiduo® Gel).acne vulgarisTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2015-002699-26-DEGWT-TUD GmbH
Completed
Not Applicable
Repeat prostate evaluation and therapy pilot study in patients undergoing high dose rate brachytherapy for prostate cancerProstate CancerCancer - ProstateACTRN12610001076066Peter MacCallum Cancer Centre13
Active, not recruiting
Not Applicable
Pilotstudie zur Verträglichkeit und Effektivität eines Artischockenpräparates bei Patienten mit chronischer Hepatitis CEUCTR2005-000687-77-DEni-Zentrum naturheilkunde16
Active, not recruiting
Not Applicable
Pilot study to evaluate the benefit and tolerability of PDM022616 on blood glucose levels in subjects with prediabetesincreased blood glucose/HbA1c/oGTT-levelsDRKS00012330Cefak KG25